![Armin Rehm, Anthea Wirges, Uta Höpken and Mario Bunse](/system/files/styles/mdc_list_teaser_mdc_mobile_1_5x/private/2023-09/%C2%A9_Felix_Petermann%2C_Max_Delbru%CC%88ck_Center_beitrag_cartemis-IMG_2250_16x10.jpg?h=bb1eff70&itok=lYwx6jWC)
Starting up with highly promising immunotherapies
After spending many years researching together, a group of scientists has founded CARTemis Therapeutics, a spin-off from the Max Delbrück Center. Uta Höpken, Armin Rehm, Anthea Wirges, and Mario Bunse want to use novel CAR T-cell therapies to help patients with cancers that are currently untreatable.